Pim Olthof

Dr. Pim Olthof is an active Researcher in the Department of Surgery at Erasmus University Medical Center, specializing in hepatobiliary and colorectal surgical oncology. His clinical research focuses on optimizing treatment protocols for gastrointestinal malignancies through nationwide collaborative studies.

His primary research interests include:

• Cholangiocarcinoma management and outcomes
• Hepatectomy techniques for liver metastases
• Rectal cancer neoadjuvant therapy optimization
• Esophageal cancer staging dilemmas
• Predictive modeling for surgical mortality

Recent work analyzes watch-and-wait strategies in rectal cancer, ypN3 esophageal cancer management, and preoperative risk scoring for liver resection.

Analysis of his 2025 publications reveals dominant focus on surgical oncology within gastrointestinal malignancies. Key trends include nationwide cohort studies evaluating locoregional recurrence patterns, lymph node metastasis risks in early-stage rectal cancer, and mortality prediction models for major hepatic resections. Subfield specialization centers on treatment personalization through risk stratification and minimally invasive approaches.

Dr. Olthof actively supervises research trainees as evidenced by Supervised Work (3) in his profile, though specific student names are not disclosed. His research is conducted through nationwide Dutch collaborations including the Dutch Snapshot Research Group and MIRECA taskforce.

His laboratory and team affiliations include:

• Erasmus MC Hepatobiliary Surgery Research Group
• Dutch Snapshot Registry Collaborators
• MIRECA (Minimally Invasive Rectal Carcinoma Surgery) Taskforce
• IVORY Study Group for esophageal cancer research